REQUEST A DEMO
Total
USD $0.00
Search more companies

Sobhan Pharmaceutical Group Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Sobhan Pharmaceutical Group Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sobhan company was established in 1976 in order to involve in development, manufacturing and marketing of generic pharmaceuticals. In 2004 the company decided to buy the majority of shares of the other pharmaceutical companies from Alborz Investment Company in order to be main shareholder and changed its name to Sobhan Pharma Group,formerly known as Sobhan Pharmaceutical Company . Currently the followings are joint companies of Sobhan Pharma group: Sobhandarou, Alborzdarou, Irandarou, Tolidarou Pharma and Sobhan Chemotherapeutic and two commercial companies which are mainly engaged in Pharmaceutical import, export and marketing activities: KBC and Swiran.

Headquarters
Argentina Square, Shahid Ahmad Qusair Street (Bucharest), Fifth Alley, No.11 - Second Floor
Tehran; Tehran; Postal Code: 1513718114

Contact Details: Purchase the Sobhan Pharmaceutical Group Company Public Joint Stock report to view the information.

Website: http://sobhanpharma.com

Basic Information
Total Employees:
Purchase the Sobhan Pharmaceutical Group Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Sobhan Pharmaceutical Group Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Sobhan Pharmaceutical Group Company Public Joint Stock report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
11%
Purchase this report to view the information.
6%
Purchase this report to view the information.
2%
Purchase this report to view the information.
1%
Purchase this report to view the information.
1%
Subsidiaries
Sobhan Darou Public Joint Stock Company
70.1%
Alborz Darou Pharmaceutical Company Public Joint Stock
68.7%
Sobhan Oncology Pharmaceutical Company Public Joint Stock
61%
Company Performance
Financial values in the chart are available after Sobhan Pharmaceutical Group Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
65.05%
Net Profit (Loss) for the Period
50.15%
Total assets
23.41%
Total equity
15.81%
Return on Equity (ROE)
2.65%
Quick Ratio
0.07%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?